(Reuters) – The U.S. Food and Drug Administration on Wednesday classified a recall of Boston Scientific (NYSE:)’s catheters used in a type of minimally invasive surgery as “most serious”.

The recall involves updating instructions for use rather than removing the device, POLARx Cryoablation Balloon Catheters, from where they are used or sold, the FDA said.

The company meanwhile is revising the use instructions of the catheter due to a higher-than-anticipated number of reports of esophageal injury, specifically a complication known as atrio-esophageal fistula, which can lead to air bubbles blocking blood vessels in the brain.

The FDA said the use of the affected products may also cause stomach and intestinal bleeding, a system-wide infection, and even death.

There have been seven reported injuries and four deaths, the health regulator added.

On Oct. 10, Boston Scientific sent an urgent medical device advisory to all affected customers with recommendations.

© Reuters. FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009. REUTERS/Jason Reed/File Photo

Boston’s device is used in ablation procedures to treat recurrent symptomatic atrial fibrillation that causes irregular, fast heartbeats lasting up to seven days and not responding to medication.

Ablation is a minimally invasive procedure used to treat atrial fibrillation by creating scars on the heart tissue.


Source link

Best Brokers

Unmatched trading fees, generous bonuses, top notch Regulation Frame.

T&Cs Apply

Risk disclosure: All investments involve a degree of risk of some kind. Trading financial derivative products comes with a high risk of losing money rapidly due to leverage.

Top-Tier Regulations. Unmatched Spreads and Commissions. Trading View is available.

T&Cs Apply

Financial Spread Trades and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84.7% of retail investor accounts lose money when trading CFDs with this provider.

Modern and Intuitive Interfaces, Solid Regulatory Frame, and excellent Trading Fees.

T&Cs Apply
Risk warning: Trading derivatives is highly speculative, carries an inherent risk of loss and is not suitable for all investors. Before trading, you are strongly advised to read and ensure that you understand the relevant risk disclosures and warnings.

Highly Regulated. Low Spreads and Commissions. Vast Account Options.

T&Cs Apply

Risk Warning: Trading derivatives carries significant risks. It is not suitable for all investors and if you are a professional client, you could lose substantially more than your initial investment.